ATRA
Atara Biotherapeutics Inc
Price:  
10.17 
USD
Volume:  
30,482.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara WACC - Weighted Average Cost of Capital

The WACC of Atara Biotherapeutics Inc (ATRA) is 16.0%.

The Cost of Equity of Atara Biotherapeutics Inc (ATRA) is 7.90%.
The Cost of Debt of Atara Biotherapeutics Inc (ATRA) is 28.45%.

Range Selected
Cost of equity 6.60% - 9.20% 7.90%
Tax rate -% - -% -%
Cost of debt 7.00% - 49.90% 28.45%
WACC 6.8% - 25.3% 16.0%
WACC

Atara WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.59 0.77
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 9.20%
Tax rate -% -%
Debt/Equity ratio 0.66 0.66
Cost of debt 7.00% 49.90%
After-tax WACC 6.8% 25.3%
Selected WACC 16.0%